OATP16 inhibitors belong to a chemical class that specifically modulates the activity of organic anion-transporting polypeptide 1B3 (OATP1B3), a member of the OATP family of membrane transport proteins. These inhibitors primarily affect the transmembrane movement of endogenous substrates, such as bile salts, hormones, and bilirubin, which are anionic and often bulky in structure. OATP transporters, including OATP1B3, are critical in facilitating the cellular uptake of various organic anions, often relying on secondary active transport mechanisms that are influenced by sodium gradients. The inhibition of OATP1B3 can lead to altered transport kinetics for substrates, potentially impacting biochemical processes tied to hepatic uptake, renal elimination, or the disposition of metabolites and xenobiotics.
Chemically, OATP16 inhibitors often possess structural features that allow them to interact with the binding sites of OATP1B3. These features typically include negatively charged or polar functional groups, such as carboxylates, sulfonates, or phosphates, which mimic the anionic nature of endogenous substrates. Such groups may facilitate competitive inhibition by occupying the substrate binding site or allosteric modulation by altering the protein's conformational state. Many inhibitors also exhibit lipophilic regions, which enhance membrane permeability, a key characteristic for interacting with transmembrane proteins. The specificity of these inhibitors for OATP1B3 can vary depending on the molecular configuration, allowing for selective inhibition over other OATP family members, which further influences the overall substrate specificity and transporter kinetics.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin could downregulate OATP16 by activating pregnane X receptor (PXR), leading to a transcriptional repression of genes coding for this transporter. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A may decrease OATP16 expression through its inhibition of calcineurin, indirectly leading to altered transcriptional activity in hepatocytes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could suppress the expression of OATP16 by inhibiting NF-κB signaling, which is often involved in the transcriptional control of membrane transporters. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $37.00 | 13 | |
Chrysin may lead to the downregulation of OATP16 by inhibiting the aromatase activity, potentially reducing estrogen levels that could have a role in OATP16 gene expression. | ||||||
Bis(2-ethylhexyl) phthalate | 117-81-7 | sc-254975 | 1 g | $56.00 | 2 | |
Bis(2-ethylhexyl) phthalate could reduce OATP16 expression by interfering with the function of peroxisome proliferator-activated receptors (PPARs), altering lipid metabolism and related transporters. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid might suppress OATP16 expression via binding to retinoic acid receptors (RARs), which can repress the transcription of some genes coding for transporters. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $56.00 $240.00 $815.00 $1305.00 | 4 | |
Erythromycin may inhibit OATP16 by competitively binding to the transporter, causing a feedback inhibition that reduces gene expression. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
Methotrexate could lead to a decrease in OATP16 expression by hindering folate metabolism, disrupting cellular replication and the expression profile of transport proteins. | ||||||
Lead(II) Acetate | 301-04-2 | sc-507473 | 5 g | $83.00 | ||
Lead (II) acetate may downregulate OATP16 through the initiation of oxidative stress pathways, leading to DNA damage and subsequent transcriptional repression. | ||||||
Benzene | 71-43-2 | sc-239290 | 1 L | $77.00 | ||
Benzene could inhibit OATP16 by inducing hematotoxicity and myelotoxicity, which may include the repression of genes coding for transport proteins in affected cells. | ||||||